Association of Plasma Renalase and Left Ventricle Mass Index in Heart Failure Patients Stratified to the Category of the Ejection Fraction: A Pilot Study. (14th October 2019)

• Record Type: Journal Article
• Authors: Stojanovic, Dijana; Mitic, Valentina; Petrovic, Dejan; Stojanovic, Miodrag; Ignjatovic, Aleksandra; Stefanovic, Nikola; Cvetkovic, Tatjana; Bojanic, Vladmila; Kocic, Gordana; Ilic, Marina Deljanin
• Other Names: Berezin Alexander Guest Editor.
• Is Part Of: Disease markers. Volume 2019(2019)
• Publication Date: 2019-10-14
• Subjects: Diagnosis -- Periodicals; Biochemical markers -- Periodicals; Pathology -- Periodicals; 616
• DOI: 10.1155/2019/7265160
• Languages: English
• ISSNs: 0278-0240

Abstract

Abstract : Heart failure represents a growing health problem, with increasing morbidity and mortality globally. According to the mechanisms involved in the pathogenesis of heart failure, many biomarkers have been proposed for the timely diagnosis and prognostication of patients with heart failure, but other than natriuretic peptides, none of them has gained enough clinical significance. Renalase, a new protein derived from kidneys was demonstrated to metabolize catecholamines and to have a cardioprotective role. The aim of the study was to determine whether renalase and brain natriuretic peptide (BNP) concentration could be used to differentiate heart failure patients stratified to the category of the ejection fraction and whether plasma renalase could be used as a biomarker for left ventricle hypertrophy in all subgroups of heart failure patients. We included patients diagnosed with heart failure and stratified them to the three subgroups according to the ejection fraction. Regarding echocardiographic parameters, HFmrEF had an intermediate profile in between HFrEF and HFpEF, with statistical significance in most evaluated parameters. BNP concentration was significantly different in all three subgroups (p < 0.001 ), and renalase was statistically higher in HFrEF (p = 0.007 ) compared to the HFmrEF and HFpEF, where its results were similar, without statistical significance. Renalase plasma concentration was demonstrated to be highly and positively associated with left ventricle mass index in HFrEF (p = 0.029 ), as well as increased plasma concentration of BNP (p = 0.006 ). In the HFmrEF group of patients, body mass index was positively associated with LVMI (p = 0.05 ), while in the patients with HFpEF, diabetes mellitus was demonstrated to have a positive association with LVMI (p = 0.043 ). These findings suggest that renalase concentration may be measured in order to differentiate patients with reduced ejection fraction. Plasma renalase concentrations positively correlated with left ventricle hypertrophy in patients with reduced ejection fraction, being strongly associated with increased left ventricular mass index.